Organizing Pneumonia: Clinical Trials

715 trials for Organizing Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

390 completed, 90 recruiting, 84 unknown, 68 terminated. 208 Phase 2, 199 Not applicable, 95 Phase 1, 86 Phase 3, 53 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2208Completed 108, Terminated 33, Recruiting 26, Unknown 21, Active not recruiting 9, Withdrawn 7, Not yet recruiting 2, Enrolling by invitation 1, Suspended 1
Not applicable199Completed 100, Recruiting 33, Unknown 29, Active not recruiting 13, Terminated 12, Not yet recruiting 8, Enrolling by invitation 2, Withdrawn 2
Phase 195Completed 53, Recruiting 12, Terminated 10, Active not recruiting 9, Withdrawn 4, Not yet recruiting 3, Unknown 3, Suspended 1
Phase 386Completed 55, Terminated 11, Unknown 7, Active not recruiting 5, Recruiting 5, Withdrawn 3
Phase 453Completed 34, Withdrawn 5, Terminated 4, Not yet recruiting 3, Unknown 3, Active not recruiting 2, Recruiting 2
Early Phase 16Completed 2, Withdrawn 2, Recruiting 1, Unknown 1

Follow Organizing Pneumonia: new trials by email Literature Review of Organizing Pneumonia trials Research Report on Organizing Pneumonia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease
Biospecimen Collection, Mindfulness Relaxation, Survey Administration - Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm
Not applicableRecruitingCity of Hope Medical Center172027-03-012026-10-16
A New ECP Protocol for the Treatment of cGVHD
Experimental ECP protocol - Chronic Graft Versus Host Disease
Not applicableNot yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS542027-01-012026-11-05
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
Belumosudil - Chronic Graft Versus Host Disease
Phase 4Not yet recruitingSanofi262026-11-202026-11-10
Study to Compare the Plasma Concentration of Belumosudil Given as an Oral Suspension and as a Tablet to Healthy Adult Male Participants
Belumosudil - Chronic Graft Versus Host Disease
Phase 1Not yet recruitingSanofi582026-11-172026-11-13
Evaluating and Promoting Resilience in Adolescents With Tourette Syndrome
PRISM Intervention, Usual care intervention - Tourette Syndrome, Tic Disorders
Not applicableNot yet recruitingWake Forest University Health Sciences952026-11-012026-10-30
A Study of Sequential Therapy With AHB-137 Injection Followed by TVAX-008 Injection in Participants Living With Chronic Hepatitis B (CHB)
AHB-137, TVAX-008, Placebo - Chronic Hepatitis B
Phase 1 / Phase 2Not yet recruitingGrand Theravac Life Sciences (Hangzhou) Co., Ltd.1052026-10-312026-10-27
Multimodal Manual Therapy vs. Maitland Mobilization for Chronic Non-Specific Neck Pain
Maitland Mobilization Treatment Approach, Manual therapy protocol - Chronic Neck Pain
Not applicableActive not recruitingUniversity of Management and Technology Lahore642026-10-272026-11-03
A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older With Chronic Graft-versus-host Disease
Belumosudil, Best available therapy (BAT) - Chronic Graft Versus Host Disease
Phase 3RecruitingSanofi3562026-10-122026-11-06
A Preliminary Clinical Study on the Efficacy of Cyclophosphamide and Sirolimus Combined With VIC-1911 in Preventing Graft-versus-Host Disease After Haploidentical Stem Cell Transplantation in Children
1mg /kg VIC-1911 - GVHD (Acute or Chronic)
Phase 1RecruitingShanghai Jiao Tong University School of Medicine92026-09-282026-10-20
A Multicentre Randomised Controlled Trial Evaluating the Efficacy of the SMILE™ Module for Improving Short-term Periodontal Outcomes, Compliance, and Acceptability Among Clinical Dental Students
SMILE Module, Conventional Toothbrushing Module - Gingivitis, Gingivitis; Chronic
Not applicableNot yet recruitingNational University of Malaysia662026-09-012026-07-15
Efficacy of Bee Venom Phonophoresis in Treating Chronic Sinusitis:
Bee Venom Phonophoresis, Standard Care (oral decongestants + saline nasal irrigation) - Chronic Sinusitis, Acute Sinusitis
Not applicableNot yet recruitingSinai University302026-08-152026-08-04
Mechanisms and Targeted Therapy of Airway Basal Cell Dysfunction in Bronchiolitis Obliterans Syndrome
Bronchoscopic brushing, Single - cell cloning, Cell function identification - Bronchiolitis Obliterans Syndrome (BOS)
Not applicableWithdrawnHaikou Affiliated Hospital of Central South University Xiangya School of Medicine2026-07-262026-07-29
AMPLIFI: Adaptive Modulation of Plasticity Through Lactate and Fitness Interventions
High intensity cycling, Low-intensity cycling, Health education session - Stroke, Chronic, Aging
Not applicableActive not recruitingUniversity of Alabama at Birmingham482026-07-152026-07-17
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
AHB-137 injection - Chronic Hepatitis B
Phase 1RecruitingAusper Biopharma Co., Ltd.322026-07-092026-07-29
Effects of Using Miswak in Addition to Oral Hygiene Products in Patients With Gingivitis
Miswak, Toothpaste - Gingivitis; Chronic
Not yet recruitingMustafa Kemal University362026-07-042026-07-08
Efficacy of an Anti-TSLP Monoclonal Antibody in the Management of Chronic Bronchial Disease Induced by Bronchiolitis Obliterans Syndrome in Allogeneic Hematopoietic Stem Cells Transplantation Recipients
Tezepelumab - Bronchiolitis Obliterans Syndrome (BOS), HSCT
Phase 2RecruitingHopital Foch362026-06-242026-08-18
Study of AHB-171 in Chronic Hepatitis B Participants
AHB-171 Injection - Hepatitis B, Chronic (CHB)
Phase 2RecruitingAusper Biopharma Co., Ltd.1382026-06-242026-07-21
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic
Phase 4RecruitingZhujiang Hospital502026-06-222026-08-25
Shortwave Infrared Surgical Imaging Device Study
Observational study of SWIR imaging device in surgery - Cholecystitis, Cholecystitis, Chronic
Enrolling by invitationCision Vision, Inc.502026-05-292026-08-04
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
EVE-Treg - Graft Versus Host Disease (cGvHD)
Phase 1RecruitingSarah Nikiforow, MD212026-05-292026-11-04

Showing 20 of 715. Sign in to see all of them.

Narrower conditions

Bronchiolitis Obliterans Syndrome (707)  ·  Pain (51)  ·  Graft vs Host Disease (46)  ·  Low Back Pain (43)  ·  Leukemia (41)  ·  Hepatitis C (22)  ·  Bronchiolitis Obliterans (21)  ·  Lymphoma, Follicular (20)  ·  Stroke (20)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (19)  ·  Motor Activity (18)  ·  Cholecystitis (17)  ·  Hematologic Neoplasms (17)  ·  Hepatitis B (17)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (17)

Broader conditions

Lung Diseases, Obstructive (714)  ·  Bronchial Diseases (713)  ·  Bronchiolitis (713)  ·  Lung Diseases (712)  ·  Respiratory Tract Diseases (712)  ·  Bronchitis (711)  ·  Immune System Diseases (703)  ·  Bronchiolitis Obliterans (694)  ·  Graft vs Host Disease (661)  ·  Pathological Conditions, Signs and Symptoms (304)  ·  Signs and Symptoms (168)  ·  Pathologic Processes (146)  ·  Neurologic Manifestations (139)  ·  Disease Attributes (110)

Interventions

belumosudil (15)  ·  ibrutinib (15)  ·  Prednisone (13)  ·  Rituximab (12)  ·  Mycophenolic Acid (11)  ·  Sirolimus (11)  ·  ruxolitinib (11)  ·  Tacrolimus (10)  ·  axatilimab (10)  ·  Photopheresis (9)  ·  Azithromycin (8)  ·  Imatinib Mesylate (8)  ·  Cyclophosphamide (7)  ·  Cyclosporine (7)  ·  KD025 (7)

Sponsors

Novartis Pharmaceuticals (17)  ·  Hoffmann-La Roche (12)  ·  Dana-Farber Cancer Institute (11)  ·  Fred Hutchinson Cancer Center (11)  ·  Incyte Corporation (11)  ·  National Cancer Institute (NCI) (10)  ·  AstraZeneca (9)  ·  Pfizer (9)  ·  Gilead Sciences (8)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  M.D. Anderson Cancer Center (7)  ·  Sanofi (6)  ·  Cairo University (5)  ·  Foundation for Liver Research (5)  ·  Karolinska Institutet (5)

Countries

United States (296)  ·  Canada (69)  ·  France (68)  ·  Germany (63)  ·  Spain (60)  ·  United Kingdom (59)  ·  China (52)  ·  Italy (52)  ·  Belgium (45)  ·  Australia (33)  ·  Netherlands (33)  ·  Poland (32)  ·  Turkey (Türkiye) (31)  ·  South Korea (29)  ·  Russia (25)

Top investigators

Stephanie Lee (5)  ·  Amandeep Salhotra (3)  ·  Esther Garcia, MD (3)  ·  John Koreth, MBBS, DPhil (3)  ·  Aldo T Iacono, MD (2)

Results publications

PMID 32816215, PMID 20965785, PMID 23861248, PMID 24432712, PMID 25287629, PMID 26149717, PMID 28396102, PMID 31260802, PMID 34265047, PMID 34433773, PMID 34773261, PMID 35235189, PMID 36440464, PMID 36791280, PMID 38696034, PMID 39704205, PMID 10387937, PMID 10619108, PMID 10845940, PMID 10997973, PMID 11172169, PMID 11222360, PMID 11509929, PMID 11756187, PMID 11784274, PMID 11981005, PMID 12070007, PMID 12095178, PMID 12359244, PMID 12364304, PMID 12444880, PMID 12931119, PMID 14512314, PMID 15142114, PMID 15251978, PMID 15292060, PMID 15613541, PMID 15621359, PMID 15772908, PMID 16046530, PMID 16186460, PMID 16186597, PMID 16239908, PMID 16326235, PMID 16407509, PMID 16446108, PMID 16551963, PMID 16788100, PMID 16946302, PMID 17035671

NIH funding

2015 (6), 2014 (5), 2016 (5), 2009 (4), 2018 (4), 2019 (4), P30CA015704 (4), 2017 (3), 2023 (3), 2025 (2), P30CA033572 (2), R01AT007987 (2), U01HL069294 (2), 1UH2DK104655-01 (1), 2005 (1)